BglF, the sensor of the E.coli bgl system, uses the same site to phosphorylate both a sugar and a regulatory protein Chen, Q.; Arents, J.C.; Bader, R.; Postma, P.W.; Amster-Choder, O.
In the presence of β-glucosides, BglF dephosphorylates BglG~P, allowing it to dimerize and function as a positive The Escherichia coli BglF protein is a sugar permease regulator of operon expression. that is a member of the phosphoenolpyruvate-depend-
The phosphoryl flux in PTS starts with a phosphoryl ent phosphotransferase system (PTS). It catalyses group donated by phosphoenolpyruvate (PEP) which is transport and phosphorylation of β-glucosides. In addipassed down a phosphoryl transfer chain which consists tion to its ability to phosphorylate its sugar substrate, of Enzyme I (EI) and HPr, which are not sugar specific, BglF has the unusual ability to phosphorylate and and Enzyme IIs (EIIs), which are specific for different dephosphorylate the transcriptional regulator BglG sugars. The EIIs are composed of at least three wellaccording to β-glucoside availability. By controlling recognized functional domains whose order is not conthe phosphorylation state of BglG, BglF controls the served: IIA is a hydrophilic domain that possesses the dimeric state of BglG and thus its ability to bind RNA first phosphorylation site, a conserved histidine which can and antiterminate transcription of the bgl operon. BglF be phosphorylated by P-HPr; IIB is a second hydrophilic has two phosphorylation sites. The first site accepts a domain that possesses the second phosphorylation site, phosphoryl group from the PTS protein HPr; the usually a conserved cysteine that can be phosphorylated phosphoryl group is then transferred to the second by P-IIA; and IIC is a hydrophobic domain which includes phosphorylation site, which can deliver it to the sugar.
6-8 transmembrane helices that presumably form the sugar We provide both in vitro and in vivo evidence that the translocation channel and at least part of its binding site same phosphorylation site on BglF, the second one, is (reviewed in Saier and Reizer, 1992; Postma et al., 1993) . in charge not only of sugar phosphorylation but also BglF is the PTS EII for β-glucosides and is also designated of BglG phosphorylation. Possible mechanisms that II bgl . Based on sequence comparisons with other PTS EIIs, ensure correct phosphoryl delivery to the right entity, several conserved residues in BglF were suggested to play sugar or protein, depending on environmental condia role in the transfer of the phosphoryl group from HPr tions, are discussed.
to BglF and from BglF to the sugar. These residues were Keywords: bgl system/β-glucosides/phosphorylation subjected to site-directed mutagenesis and the phosphosites/protein phosphorylation/PTS rylation performance of the respective mutants was studied . His547 (H547), located in the IIA domain, was identified as the first phosphorylation site
Introduction
(site 1), which is phosphorylated by HPr and transfers the phosphoryl group to the second phosphorylation site The Escherichia coli BglF protein, which is a member (site 2). Two residues were candidates for the second of the phosphoenolpyruvate-dependent phosphotransferase phosphorylation site, Cys24 (C24) and His306 (H306), system (PTS), catalyses concomitant transport and both shown to be essential for the transfer of the phosphoryl phosphorylation of β-glucosides (Fox and Wilson, 1968) .
group to the sugar. Based on the vast amount of information In addition to its role in sugar transport, BglF functions available on phosphorylation sites in related permeases as a negative regulator of bgl operon expression , and references therein), it was logical . This property of the enzyme is to assume that C24, which is located in the IIB domain, due to its unprecedented ability to phosphorylate not only and not H306, located in the IIC domain, is the residue its sugar substrate but also a protein essential for operon which accepts the phosphoryl group from H547 and expression, BglG, a property not yet demonstrated for any transfers it on to the sugar, while H306, located in the IIC other protein (Amster-Choder et al., 1989) . BglG is an domain, is involved in transporting the sugar. In vitro RNA-binding protein which controls bgl operon expresphosphorylation experiments with distinct domains have sion by transcriptional antitermination (Mahadevan and shown unambiguously that the second phosphorylation Schnetz and Rak, 1988; Houman et al., site resides in the IIB domain of BglF and not in the IIC 1990). regulator BglG? The basis for the ability of a protein to
Results
phosphorylate such different entities as a carbohydrate To test which site(s) on BglF are involved in transfer of and a protein is unknown. Knowledge of whether a single a phosphoryl group to β-glucosides and BglG, we mutated phosphorylation site performs both transfer reactions or each of the two phosphorylation sites on BglF. His547 whether two different sites are involved, one for each was mutated to an arginine (H547R), and Cys24 was reaction, is crucial for elucidating the relationship between mutated to a serine (C24S) (see Materials and methods). recognition and phosphorylation. It was suggested preWe then followed the ability of the mutant proteins to be viously that each of the two phosphorylation sites on phosphorylated and to donate the phosphoryl group to BglF is in charge of a different phosphorylation function β-glucosides and to BglG in vitro on one hand, and to , i.e. the site on IIA bgl phosphorylmediate β-glucoside utilization and to modulate BglG ates BglG and the site on IIB bgl phosphorylates the activity in vivo on the other hand. sugar. These authors also suggested that IIA glc , which is homologous to the IIA bgl domain (Bramley and Kornberg, 1987) and was shown to complement BglF mutated in Phosphorylation of wild-type and mutant BglF proteins site 1 , can transfer phosphoryl groups not only to site 2 of BglF but also to BglG.
Membranes containing wild-type BglF, or BglF mutated in either one of its phosphorylation sites (C24S or H547R), However, the observation that no [ 32 P]BglG was detected when non-phosphorylated BglG was incubated with were incubated in the in vitro phosphorylation system described previously (Amster-Choder et al., 1989) . The [ 32 P]PEP and a soluble fraction of a Salmonella typhimurium strain overproducing EI, HPr and IIA glc (Amstersystem, which will be referred to as system A, is crude and contains [ 32 P]PEP, a cytoplasmic extract prepared Choder et al., 1989) did not support transfer from IIA glc to BglG. Here we provide both in vivo and in vitro from the mutant strain of S.typhimurium LJ144 which expresses increased amounts of EI, HPr and IIA glc (Saier evidence that the site on BglF which transfers a phosphoryl group to β-glucosides, site 2, is the same one that is used and Feucht, 1975) , and membranes prepared from E.coli K38 cells expressing the bglF alleles under the control of for transfer of a phosphoryl group to BglG. Thus, the phosphoryl group is transferred from site 1 to site 2 and phage T7 promoter. All three BglF derivatives were detected by autoradiography following SDS-PAGE then to either the sugar or to BglG. Therefore, not only is BglF unique in its ability to phosphorylate both a sugar ( Figure 1A , lanes 1-3). This polypeptide could not be detected when membranes of cells containing a similar and a regulatory protein, but, more interestingly, the phosphoryl group is donated to these totally different plasmid which lacks the bglF gene were included in this in vitro system ( Figure 1A , lane 4). entities by the same site. Possible mechanisms that ensure correct phosphoryl delivery to the right entity, depending Subsequently, we have expressed the three bglF alleles (wild-type and the two mutants) in E.coli LM1, a strain on environmental conditions, are discussed.
wild-type BglF and is completely dephosphorylated upon addition of salicin (compare lane 3 with lane 4 and lane 5 with lane 6, for the wild-type and site 1 mutant, respectively). The phosphorylated site 2 mutant protein (C24S), on the other hand, is not chased by salicin ( Figure  2 , lanes 7 and 8).
IICB glc , which is present in our membrane preparations in a significant amount (as demonstrated by Western blot analysis using monoclonal antibodies raised against this protein, data not shown), was reported to be phosphorylated by the IIA domain of BglF (Vogler et al., 1988; Schnetz et al., 1990) . It can therefore lead to some dephosphorylation of BglF, which is independent of β-glucosides, due to the the presence of residual glucose contamination, detected occasionally in commercial salicin. To avoid this complication, the membranes con- Figure 1B (lanes 1-3) , demonstrate et al., 1989) . The physiological significance of this result was demonstrated by the correlation between the behaviour that the site 2 mutant (C24S) behaved like wild-type BglF, while a mutation in site 1 (H547R) abolished the ability of BglG mutants in vivo and their phosphorylation behaviour in vitro. BglF-dependent phosphorylation of BglG of BglF to be phosphorylated by HPr. The control reaction contained membranes of LM1 bearing a similar plasmid was also demonstrated in vivo (Amster-Choder and . Thus the ability of BglG to be phosphorylated in lacking the bglF gene ( Figure 1B , lane 4). Addition of purified IIA glc restored site 1 mutant phosphorylation vitro is an excellent indication for the in vivo situation. We have tested the effect of the mutations in the (compare lanes 3 and 7 in Figure 1B ) while it did not affect phosphorylation of wild-type BglF and the site 2 phosphorylation sites of BglF on its ability to phosphorylate BglG. An extract of cells overproducing BglG (see mutant ( Figure 1B , lanes 5 and 6 versus lanes 1 and 2). Thus BglF mutants are behaving as expected in the two Materials and methods) was added to mixtures containing the different BglF variants that had been pre-labelled for in vitro systems utilized by us; BglF mutated in site 1 cannot accept a phosphoryl group from HPr, but this 10 min in system A. As was shown in Figure 1A , all three BglF variants examined (wild-type and mutants) are mutation can be complemented by IIA glc , while a mutation in site 2 does not interfere with BglF phosphorylation by phosphorylated in this system (the site 1 mutant is labelled due to the presence of IIA glc in this phosphorylation HPr. This is in agreement with the previously suggested heterologous phosphoryl transfer from IIA glc to site 2 of system, see above) and we could thus test their ability to transfer the phosphoryl group to BglG. The results, preBglF . sented in Figure 3 , demonstrate that a mutation in the first phosphorylation site of BglF does not prevent this protein
Dephosphorylation of wild-type and mutant BglF proteins by β-glucosides from phosphorylating BglG. Some phosphorylation of BglG was detected 1 min after the addition of the BglGAll of the published evidence to date suggests that the second phosphorylation site on BglF is the one involved containing extract, and the amount of phosphorylated BglG increased with time of incubation ( Figure 3 , lanes in transferring the phosphoryl group to the sugar substrate. We have tested the ability of our mutant BglF proteins, 9-12). The slight difference from the phosphorylation pattern of BglG by wild-type BglF ( Figure 3 , lanes 1-4) pre-labelled by incubation with [ 32 P]PEP, and purified EI and HPr to donate a phosphoryl group to the β-glucoside can be explained by the fact that H547R is labelled by IIA glc and the phosphoryl flow is expected to be less salicin. As seen in Figure 2 , the site 1 mutant protein (H547R), once phosphorylated by IIA glc , behaves like efficient in this heterologous system than in the wild-type Membranes containing the various BglF derivatives (wild-type, C24S and H547R) were labelled in phosphorylation system A, as described in Figure 1A . Extract of cells that overproduce BglG was added, and incubation was continued for the times indicated. Samples were analysed by SDS-PAGE followed by autoradiography. Lane 13 contains a 35 S-labelled sample of BglG. Molecular masses of protein standards are given in kilodaltons. Arrowheads indicate the positions of BglF and BglG. MBP-BglG (BglG fused to maltose-binding protein) which is soluble and can be purified on an amylose column (see Materials and methods). We first demonstrated that this fusion protein can be phosphorylated by wild-type BglF in vitro ( Figure 4A , lane 2). To ensure that it is the BglG, and not the MBP moiety, that is phosphorylated by BglF, we incubated purified MBP with pre-labelled BglF presented in Figure 5 , demonstrate that MBP-BglG can EI co-migrates with BglF in this gel system (see Figure 5 ).
be phosphorylated by the site 1 mutant which was labelled in a reaction supplemented with IIA glc (lane 7), but not by the site 2 mutant (lanes 3 and 6). No phosphorylation of MBP-BglG could be detected when it was added to situation which involves intramolecular transfer of the phosphoryl group. In contrast to the behaviour of the membranes of cells that do not produce BglF, which were pre-labelled in phosphorylation system B ( Figure 5 , lane site 1 mutant, no phosphorylation of BglG occurred with BglF mutated in site 2, even after incubating the labelled 1). Thus, phosphorylated EI and HPr cannot phosphorylate BglG. C24S with the BglG-containing extract for 15 min ( Figure  3 , lanes 5-8). Longer periods of incubation gave the same Taken together, these results show conclusively that the second phosphorylation site in BglF (C24), and not the result (data not shown).
To assay for BglG phosphorylation by BglF in a purified first, is in charge of delivering the phosphoryl group to BglG. These results also rule out the possibility raised system, and in light of the difficulty in purifying BglG due to its irreversible precipitation in inclusion bodies before ) that phosphorylated IIA glc can deliver the phosphoryl group to BglG (see Figure 5 , upon overproduction (A.Wright, unpublished data), we decided to measure phosphorylation of the fusion protein lane 6). β-glucoside phosphotransfer mediated by Thus, β-glucoside utilization can be restored in bglF strains by a plasmid-encoded BglF mutated in the first wild-type and mutant BglF proteins Next we decided to substantiate our in vitro results phosphorylation site, provided that the strain produces IIA glc . The slight difference between the effect of the regarding BglF-dependent BglG phosphorylation by in vivo studies. We first verified that our mutants behave as wild-type BglF and the site 1 mutant, observed with some strains (all originating from the same parental strain) in one expected with regard to β-glucoside utilization.
To analyse the ability of the various BglF derivatives of the complementation tests, i.e. colour on MacConkey arbutin, can be explained by the more efficient phosphoryl to transfer β-glucosides into the cell while phosphorylating them, we used strains defective in the bglF gene, and transfer from site 1 to site 2 when both sites are present on the same molecule than in the heterologous system carried out complementation analyses with a series of plasmids encoding BglF derivatives: pMN5 and pCQ-F (which necessitates phosphoryl flow from IIA glc to site 2 of BglF). The other test, growth on minimal arbutin, is encode wild-type BglF; pCQ-F1 and pCQ-F2 encode BglF mutated in the first and second phosphorylation sites not sensitive to this difference. Also, strain MA231, which gives bright red colonies on MacConkey arbutin when (H547R and C24S), respectively. Positive complementation of the chromosomal mutation in the bglF gene transformed with pCQ-F1, might have a slighty higher level of IIA glc which compensates for the intramolecular by the plasmid-encoded alleles was indicated both by growth on minimal medium containing arbutin as the sole phosphoryl transfer. Based on the results presented in this section, it can be carbon source and by the formation of red colonies on MacConkey arbutin plates. Utilization of the β-glucoside concluded that our mutants behave as expected with regard to phosphotransfer of β-glucosides into the bacterial cell. arbutin depends on the ability of the plasmid-encoded BglF derivatives to phosphorylate and transport this sugar which is then cleaved by the product of the unlinked locus
The effect of wild-type and mutant BglF proteins on BglG activity as a transcriptional bglA. Utilization of the β-glucoside salicin is prohibited in these strains due to the polarity of the mutation in the antiterminator BglF was shown before to exert its negative effect on chromosomal bglF gene on the adjacent bglB gene, whose product preferentially cleaves phosphosalicin (Mahadevan operon expression by phosphorylating BglG, blocking its action as an antiterminator (Amster-Choder et al., 1989 . We used several bglF strains which are wildtype for crr and nagE , and also
To establish which phosphorylation site on BglF is responsible for BglG negative regulation by phosphorylation, we isogenic strains defective in the crr and nagE genes which we have constructed (see Materials and methods). The tested the effect of the mutations in the two phosphorylation sites of BglF on the protein's ability to negatively results are presented in Table I . While the control wildtype bglF plasmids (pMN5 and pCQ-F) complemented regulate BglG. To address this question, we made use of strain MA200-1, whose chromosome carries a bglЈ-lacZ all the bglF strains to Arb ϩ (growth on minimal arbutin and red colonies on MacConkey arbutin), a mutation in fusion (a fusion of the bgl promoter and transcription terminator to lacZ) and a mutation in the bglF gene site 2 abolished the ability of the plasmid-encoded BglF to complement any of these strains (no growth on minimal . Due to the mutation in the chromosomal bglF gene, BglG is not negatively regulated arbutin and white colonies on MacConkey arbutin in all strains containing pCQ-F2). The site 1 mutant (encoded in this strain and therefore enables constitutive expression of the lacZ gene. Expression of plasmid-encoded wildby pCQ-F1) showed no complementation in bglF strains defective in the crr gene. However, bglF strains carrying type BglF protein in MA200-1 renders lacZ expression inducible, i.e. β-galactosidase is produced only upon the wild-type crr gene were complemented by the site 1 mutant and grew on minimal arbutin. They also led to the addition of β-glucosides to the growth medium. The β-galactosidase levels measured in MA200-1-containing formation of red colonies on MacConkey arbutin, though paler in some cases than the same strains containing a plasmids which encode the various BglF derivatives, pCQ-F1 and pCQ-F2, in the absence and presence of plasmid which encodes wild-type BglF. a MA200-1 is Bgl ϩ and it carries a bgl-lacZ transcriptional fusion. PPA546 and PPA547 are derivatives of MA200-1 but their crr and nagE genes were mutated. b 10 mM β-methylglucoside (βMG) were added to the growth medium when indicated. c 7 mM salicin were added to the growth medium when indicated.
β-glucosides, are given in Table II . BglF mutated in site 1 phosphorylation function. According to their model, in the absence of sugar, the phosphoryl group in site 1 cannot (H547R) behaved like wild-type BglF, allowing lacZ expression only upon addition of β-glucosides (two types be drained by site 2 to the sugar, leaving site 1 permanently phosphorylated; the phosphoryl group is then transferred of β-glucosides were used in this assay, salicin or β-methyl glucoside). Mutation in site 2 (C24S) abolished the ability from site 1 to BglG. They also suggested that IIA glc , which is homologous to the IIA bgl domain (Bramley and of BglF to negatively regulate BglG and could not prevent constitutive expression of lacZ. Kornberg, 1987) and can complement BglF mutated in site 1 ; this study), can transfer In order to study BglG regulation in a background deficient for IIA glc and II nag , which can substitute for phosphoryl groups to site 2 of BglF or to BglG. However, the fact that no [ 32 P]BglG was detected when non-IIA bgl (and thus complement for mutations in this domain of BglF), we constructed two strains, PPA546 and PPA547, phosphorylated BglG was incubated with [ 32 P]PEP and a cellular fraction enriched for EI, HPr and IIA glc (Amsterwhich are defective in their crr and nagE genes but are otherwise isogenic to MA200-1 (see Materials and Choder et al., 1989) did not support this model. As a matter of fact, despite the model presented by Schnetz methods). Introduction of pCQ-F1 and pCQ-F2 into these strains demonstrated that both BglF mutants were unable and Rak, their results did not rule out the possibility that the same site, site 2, is in charge of both phosphorylation to regulate BglG and prevent constitutive expression of lacZ in this background. The control plasmid-encoded functions, i.e. sugar and BglG phosphorylation.
The results presented here demonstrate that the phoswild-type BglF allowed for lacZ expression only in the presence of β-glucosides, as in MA200-1 (Table II) .
phoryl group is transferred from site 1 of BglF, His547, to its site 2, Cys24, and then either to the sugar or to We can thus conclude unequivocally that the second phosphorylation site in BglF is in charge of BglG negative BglG. This conclusion is based on in vitro and in vivo studies with BglF mutated either in site 1 (H547R) or in regulation in vivo. IIA glc cannot complement or override the mutation in this site with respect to BglG regulation. site 2 (C24S). Our in vitro studies prove unequivocally that the mutants behave the same with regard to their However, a mutation in the first phosphorylation site of BglF, a site not involved in BglG regulation, can be ability to transfer the phosphoryl group to β-glucosides and to BglG. A mutation in site 1 affects the ability of complemented by IIA glc as expected, and very likely by II nag as well.
BglF to be phosphorylated by HPr but, once the mutant acquires a phosphoryl group on its second unchanged site (with the help of IIA glc which can substitute for a defective
Discussion
IIA bgl ), it can transfer it both to the sugar and to BglG. A mutation in the second phosphorylation site abolishes both It has been shown previously that BglF catalyses phosphorylation of either β-glucosides or a regulatory protein, activities, sugar and BglG phosphorylation. It is thus obvious that the second site is the one that donates the BglG, depending on environmental conditions (AmsterChoder et al., 1989; Amster-Choder and Wright, 1990;  phosphoryl group to both entities. To remove any doubt that these results have relevance for the in vivo situation, Schnetz and Rak, 1990) . BglF, an EII of the PTS, has two phosphorylation sites. Similarly to other EIIs, the we have also shown that the effect of the mutations in BglF on its biological functions is consistent with the phosphoryl flows from the PTS protein HPr to the first phosphorylation site ('site 1') of BglF and then to its phosphoryl flux demonstrated in vitro. Since BglF inhibits BglG activity as a transcriptional antiterminator by second site ('site 2'), which can deliver it to the sugar. How is BglG phosphorylation carried out by BglF? It has phosphorylation, we expected a mutation in the site which is in charge of BglG phosphorylation to cancel the ability been suggested by Schnetz and Rak (1990) that each of the two phosphorylation sites on BglF is in charge of one of BglF to inhibit BglG action. Indeed, BglF mutated in site 2, which prevents the bacterial cell from utilizing phosphoryl group back to Cys24 of BglF. Such phosphoryl flow from BglG back to BglF is the reverse reaction β-glucosides, cannot negatively regulate BglG activity. A mutation in site 1 affected both functions of BglF only in of BglG phosphorylation. The phosphorylation reactions between the different components of PTS were shown to a strain deficient for the proteins IIA glc and II nag . In strains expressing these proteins, that can complement the be reversible in all cases when reversibility was tested. However, BglG is not a PTS member, according to the mutation in site 1 of BglF and deliver the phosphoryl group from HPr to site 2 of BglF, the site 1 mutant carried current definition of PTS proteins, since in no other case has a PTS EII been shown to phosphorylate a non-PTS out both functions.
A model for the phosphoryl flux from PEP to the protein, though it was suggested in several cases (see below). Further studies of the phosphorylation reaction of components of the bgl system, which is consistent with our observations, is shown in Figure 6 . A phosphoryl BglG by BglF, which we intend to pursue in the future, should provide an answer to whether this reaction is group is transferred from PEP through EI and HPr to the IIA domains of PTS proteins, among them IIA bgl and IIA glc , reversible. the latter being a key regulatory protein constitutively produced in the E.coli cell. These two IIAs, which are Mechanisms that can possibly control phosphoryl flux in the bgl system homologous to each other, are phosphorylated on a histidine residue, IIA bgl on His547 and IIA glc on His90. The What are the possible mechanisms that allow the β-glucosides to divert the phosphoryl group away from phosphoryl group can be transferred from each of these histidines to Cys24 in the IIB bgl domain. Under nonBglG to sugar transport? The key is likely to lie in different recognition of the two entities, sugar and protein, inducing conditions, Cys24 of BglF delivers phosphoryl groups to the BglG molecules present in the cell. Phosby BglF. Different recognition can be achieved by different recognition sites for the sugar and for BglG, by alternative phorylated BglG cannot dimerize and thus cannot bind to the bgl transcript and antiterminate transcription. Tranconformations that BglF can adopt under different conditions, and by a combination of both. Because the same scription of the bgl operon is terminated prematurely. Addition of β-glucosides stimulates BglF to dephosphorylactive site on BglF delivers the phosphoryl group to BglG and to β-glucosides, recognition of the two entities is ate BglG and to phosphorylate the β-glucosides (AmsterChoder et al., 1989; Amster-Choder and Wright, 1990 ). expected to be specified by sites other than the active site. If this is the case, it should be possible to engineer or Non-phosphorylated BglG dimerizes, binds its RNA target, antiterminates transcription of the bgl operon and leads select for BglF derivatives that can transport β-glucosides but cannot regulate BglG, or vice versa. We have preliminto Bgl protein production. More β-glucosides can be phosphorylated and transported into the cell. Thus, under ary evidence that such variants of BglF exist (Q.Chen and O.Amster-Choder, unpublished data). inducing conditions, the phosphoryl group is donated to the sugar by the phosphorylated Cys24, which is the same The recognition sites are not necessarily expected to be specified by a consecutive sequence of amino acids. They residue responsible for the phosphorylation of BglG under non-inducing conditions. The graphic illustration, showing might rather be created by sequences in different domains of BglF (which is composed of three distinct domains) the involvement of Cys24 in BglG dephosphorylation, represents a suggestion by which BglG can deliver the that are brought together due to a certain way of folding of the protein. An intriguing mechanism might be that the Bgl proteins and nucleotide sequence homology to the cis elements involved in bgl operon induction, several systems sugar induces a conformational change by binding to the BglF permease: a sugar-bound permease dephosphorylates were suggested to affiliate to the bgl family of sensory systems. These systems seem to consist of BglG-like BglG and phosphorylates the sugar; BglF, not bound to sugar, folds into a conformation that phosphorylates BglG.
antiterminators negatively regulated by BglF-like EIIs. BglP and SacX from Bacillus subtilis are examples of An example of such a conformational change is dimerization of BglF, which might be induced by substrate binding, proteins that were suggested to perform similarly to BglF. BglP, the B.subtilis β-glucoside phosphotransferase EII, similarly to ligand-induced dimerization of eukaryotic receptors. This possibility is currently under study. Morenegatively regulates the activity of LicT, a BglG-like transcriptional antiterminator (Kruger and Hecker, 1995 ; over, BglF might alternate between a sugar-bound conformation and a BglG-bound conformation, the first being Le Coq et al., 1995) . SacX, which shows strong homology to sucrose-specific PTS permeases (Zukowski et al., 1990 ), more favourable. Since BglG is a soluble protein present in catalytic amounts in the cell, a likely possibility that negatively regulates the activity of SacY (Aymerich and Steinmetz, 1987) , another BglG homologue (Aymerich can ensure rapid and efficient response to environmental changes is recruitment of BglG molecules to the memand Steinmetz, 1992) . The similarity of these protein pairs to the bgl system led to the proposal, yet to be proven, brane. The physical attachment between BglF and BglG, if it exists, is expected to prevail as long as BglF is not that BglP and SacX play a similar role to BglF and inhibit the antitermination activity of LicT and SacY, respectively, bound to the sugar; induction of a conformational change in BglF due to binding of β-glucosides might very well by phosphorylation. Unlike BglF, SacX constitutes only part of the EII sucrose permease, and its counterpart has lead not only to dephosphorylation of BglG, but also to its detachment from BglF due to lack of affinity between not been identified indisputably yet. Another putative bgllike system in B.subtilis is composed of the four proteins the sugar-bound conformation of BglF and BglG. Alternatively, the detachment might be the result of the conformasuggested to form a PTS EII complex, designated lev-PTS, and the transcriptional regulator LevR, which has tional change that dephosphorylation induces in BglG, i.e. BglG dimerization. The latter option is less favourable one domain homologous to BglG Debarbouille et al., 1991) . Interestingly, unlike since it requires dimerization of membrane-bound BglG rather than dimerization of free and soluble BglG. Such BglG, LevR, as well as another BglG-like antiterminator from B.subtilis, SacT, were shown to be positively regua process does not seem to be adequate for generating a quick response to the external stimulus, which is the lated and in vitro phosphorylated by the PTS general proteins, EI and HPr (Arnaud et al., 1992 (Arnaud et al., , 1996 Stulke presence of β-glucosides. et al., 1995) . This does not rule out the possibility that these proteins are also negatively regulated by phosphoryl-
Does BglF represent a new class of EIIs of PTS?
The bgl system in E.coli is the first member of a new ation by their BglF-like partners. Another bgl-like system seems to exist in Erwinia chrysanthemi. Based on sequence family of bacterial systems involved in signal transduction (Amster-Choder and Wright, 1993) . Indeed the BglF is a homology between the arb genes in this organism and the bgl operon in E.coli, the arbF gene product was also PTS permease, and as such is responsible for the transfer of a sugar into the cell while phosphorylating it. However, suggested to resemble BglF and, in addition to β-glucoside phosphotransfer, to negatively regulate the arbG gene BglF has novel capabilities, not yet demonstrated for any other PTS permease; in addition to phosphorylating product, suggested to resemble BglG (El Hassouni et al., 1992) . Thus, indirect indications for the existence of carbohydrates, BglF phosphorylates and dephosphorylates the transcriptional regulator BglG (Amster-Choder et al.,
BglF-like EIIs that regulate the activity of their cognate transcriptional antiterminators by reversible phosphoryl-1989; Amster-Choder and Schnetz and Rak, 1990) , which leads to transcription antitermination via a ation keep accumulating. They are based on resemblance to bgl and await direct proof, biochemical or otherwise. novel mechanism (Houman et al., 1990) . BglF, together with BglG, constitutes a system which transduces a signal Nevertheless, it seems that the definition of PTS proteins might have to be extended in the future to include the from the cell surface to the transcription machinery and thus controls gene expression in response to an external PTS-dependent transcriptional antiterminators. It is too early to ask whether the BglF-like permeases use the same stimulus. Although the bgl system is composed of two components, a sensor and a response-regulator, it is not a active site to phosphorylate their sugar substrate and cognate antiterminator protein. However, an intelligent member of the family of two-component systems involved in processing sensory data and regulating gene expression guess is that they do, since the use of the same active site for the two phosphorylation reactions is probably not a (reviewed in Parkinson et al., 1993; Russo and Silhavy, 1993) . This is because the Bgl proteins do not share any coincidence. Rather, it seems to be an inherent feature of the mechanism underlying signal transduction, that reflects homology with proteins of the two-component family which was studied intensively in bacteria and later disthe competition of the two entities for the phosphoryl group, to prevent phosphorylation of both simultaneously covered in eukaryotes (reviewed in Swanson and Simon, 1994) .
and to ensure efficient response to the stimulus. Is BglF a unique EII of PTS, or do other PTS permeases stretch their activity beyond sugar phosphotransfer and
Materials and methods
control the activity of transcription regulatory proteins by phosphorylation? Although not directly proven yet, BglFStrains like PTS EIIs were suggested to exist in various organisms.
The E.coli K12 strains used in this work are listed in Table III . LM1 contains mutations in the nagE and crr genes which code for II nag and Based on predicted amino acid sequence homology to the IIA glc respectively. MA231, AE304-1, AE304-2 and AE304-4 carry a the T7 lysozyme gene cloned in pACYC184 (Studier et al., 1990) . Plasmid pGE82 which carries the recA ϩ gene and confers kanamycin defective bglF gene. MA200-1 carries a bglЈ-lacZ fusion on its chromosome and a defective bglF gene. PPA543 is a crr and nagE derivative resistance was obtained from R.A.Bender and was used during strain construction (see Table III ). of AE304-4; PPA546 and PPA547 are crr and nagE derivatives of MA200-1. Construction of these strains involved the construction of Media several intermediary strains, all listed in Table III. Enriched media, M9 salts and M63 salts minimal media were prepared P1 phage transductions were conducted as described by Arber (1958) .
essentially as described by Miller (1972) . The minimal medium used Tn10 excision was indicated by growth on fusaric acid plates which for [ 35 S]methionine labelling was the same as that used by Tabor and enable the selection for loss of tetracycline resistance (Maloy and Nunn, Richardson (1985) with 0.4% succinate as carbon source. Ampicillin 1981). The mutations in the crr and nagE genes were confirmed by the (200 µg/ml), kanamycin (30 µg/ml), tetracycline (10 µg/ml) or chloraminability of the mutants to grow on succinate and the ability to grow in phenicol (30 µg/ml) were included in the media when growing strains the presence of streptozotocin (Lengeler, 1980) , respectively. The crr which carry transposable elements or contain plasmids that confer genotype of PPA543, PPA546 and PPA547 was also confirmed by the resistance to either one of these antibiotics. Fusaric acid plates were lack of IIA glc in rocket electrophoresis experiments using antibodies prepared as described by Maloy and Nunn (1981) . Plates containing against IIA glc (Scholte et al., 1981) . The nagE genotype is linked to streptozotocin were prepared as described by Lengeler (1980) . streptozotocin resistance and was used to identify the nagE transductants MacConkey arbutin plates were prepared as described previously (Lengeler, 1980) . (Schaefler, 1967) . MacConkey lactose plates were prepared from lactose The S.typhimurium strain LJ144 contains the ptsHI-crr genes on an MacConkey agar (Difco). Minimal arbutin plates were prepared from E.coli plasmid, FЈ198, and thus produces increased levels of EI, HPr, M9 salts minimal medium supplied with 0.4% arbutin. and IIA glc (Saier and Feucht, 1975 et al., 1989) . Plasmids pT7CQ-F1 and pT7CQ-F2 are derivatives of IICB glc were obtained from B.Erni. pT7OAC-F that encode for BglF with either the His547 mutated to Arg (H547R) or the Cys24 mutated to Ser (C24S) respectively (the procedure Molecular cloning for site-directed mutagenesis is described below). Plasmid pMN5 carries All manipulations with recombinant DNA were carried out by standard the entire bglF gene cloned in pBR322 .
procedures (Maniatis et al., 1989) . Restriction enzymes and other Plasmids pCQ-F1 and pCQ-F2 contain a 2099 bp HindIII-EcoRI enzymes used in recombinant DNA experiments were purchased commerfragment from pT7CQ-F1 (encoding the H547R mutant) or from pT7CQ-cially and were used according to the specifications of the manufacturers. F2 (encoding the C24S mutant) ligated to the 4330 bp HindIII-EcoRI fragment of pBR322 respectively. Plasmid pMBP-BglG, obtained from
Measurements of β-galactosidase activity Assays for β-galactosidase activity were carried out as described by A.Wright, carries a fusion between the MalE gene and the entire bglG gene cloned downstream of the Ptac promoter. Plasmid pLysS carries Miller (1972) . Cells were grown in minimal medium which was supplemented with 0.2% lactate as carbon source. Due to a crr mutation Western blot analysis Protein extracts were fractionated on a 5-12.5% gradient SDS-polyacrylin two out of the three strains used, we supplemented the medium in all amide gel and blotted onto a nitrocellulose filter (Schleicher & Schuell) cases with 5 mM cAMP. using transfer buffer (25 mM Tris, 190 mM glycine, 20% methanol). The nitrocellulose membrane was then blocked by incubation in 1% fat Preparation of cell extracts and membrane fractions milk for 1 h at room temperature. Incubation with anti-MBP antiserum, Cell extracts enriched for BglG and membrane fractions enriched for diluted 1:5000 in 1% fat milk, was carried out overnight at 4°C and was the various BglF derivatives (wild-type, H547R and C24S) were prepared followed by three washes of 5 min in phosphate-buffered saline (PBS; as described before (Amster-Choder et al., 1989) . The proteins were 80 mM Na 2 HPO 4 , 20 mM NaH 2 PO 4 and 100 mM NaCl). Alkaline expressed from their respective genes cloned under T7 promoter control phosphatase-conjugated goat anti-rabbit IgGs (Jackson ImmunoResearch in plasmids pT7FH-G, pT7OAC-F, pT7CQ-F1 and pT7CQ-F2. ExpresLaboratories Inc.) were diluted 1:5000 in 1% fat milk and the blot was sion of T7 RNA polymerase, specified by plasmid pGP1-2 which is incubated in it for 2 h at room temperature. The blot was then washed compatible with the above plasmids, was induced thermally. For preparing three times in PBS for 5 min, once in AP buffer (100 mM Tris-HCl, extracts and membranes used in the in vitro phosphorylation system A pH 9.5, 100 mM NaCl, 5 mM MgCl 2 ) for 10 min and developed in a (see below), the E.coli K38 strain was used as a host. The E.coli LM1 solution of 0.33 mg/ml NBT (nitro blue tetrazolium, Sigma) and strain, containing mutations in the crr and nagE genes that code for 0.165 mg/ml BCIP (5-bromo-4-chloro-3-indolyl phosphate, Sigma) in IIA glc and II nag respectively, was used as a host when preparing cellular AP buffer. fractions used in the in vitro phosphorylation system B. Membranes of the E.coli strain ZSC112∆G were used to study dephosphorylation of Cells containing the plasmids carrying the bglF or bglG genes under the Membrane fractions lacking BglF were prepared either from strain control of the phage T7 promoter were induced and labelled with K38/pGP1-2/pT712 or from strain LM1/pGP1-2/pT712 and were used [ 35 S]methionine in the presence of rifampicin (Sigma) as described by in control experiments in phosphorylation systems A or B respectively. Tabor and Richardson (1985) . A soluble fraction from S.typhimurium LJ144, which overproduces EI, HPr and IIA glc , was prepared as described by Begley et al. (1982) .
Site-directed mutagenesis Site-directed mutagenesis was carried out by overlap extension with Purification of MBP-BglG PCR as described by Ho et al. (1989) . The primers 5Ј-CTGATGCATAThe expression and purification of MBP-BglG were carried out basically GCGCTACGCGA-3Ј and its complementary oligo, or 5Ј-ATCCTGas recommended by New England Biolabs with some modifications. A ATACGCGTCGGTATC-3Ј and its complementary oligo were used to culture of MC1061/pLysS/pMBP-BglG was grown with aeration to mutate the bglF gene to its alleles that encode BglF derivatives with the OD 600 ϭ 0.3 in L broth containing 0.1% glucose, 200 µg/ml ampicillin Cys24 replaced by Ser or the His547 replaced by Arg, respectively. The and 30 µg/ml chloramphenicol at 37°C. Isopropyl-β-D-thiogalactopyranomutations introduced new sites for restriction enzymes which were side (IPTG) was added to a final concentration of 0.07 mM, to induce useful during the screening for the mutant plasmids. The mutations were expression of pMBP-BglG, and growth was continued with aeration for confirmed by sequencing. an additional 2 h. The cells were then harvested by centrifugation at 4000 g for 20 min in the cold and the pelleted cells were frozen. Freezing and thawing the cells enhance lysis by the lysozyme expressed from Electrophoresis and autoradiography pLysS. The pellet was resuspended in column buffer [20 mM Tris-HCl, Proteins were incubated for 30 min at 30°C in electrophoresis sample buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 5% pH 7.5, 200 mM NaCl, 1 mM EDTA, 20 mM phenylmethylsulfonyl β-mercaptoethanol, 10% glycerol and 0.01% bromophenol blue. In fluoride (PMSF)] and sonicated. After removal of unbroken cells by most cases, electrophoresis of proteins was carried out on 10% SDScentrifugation at 4000 g for 20 min, the supernatant was mixed gently polyacrylamide gels as described by Laemmli (1970) . Gradient with 1/10 volume of amylose resin overnight at 4°C. The resin then was SDS-polyacrylamide gels (5-12.5%) were used where indicated. After packed in a column. The column was washed once with column buffer, electrophoresis, gels were dried and exposed to Kodak XAR-5 X-ray once with column buffer containing 0.01% Triton X-100, and again with film at -70°C. column buffer. The MBP-BglG was eluted with column buffer containing 10 mM maltose, and fractions were collected. The fractions were analysed by SDS-PAGE and those containing MBP-BglG were dialysed against column buffer to remove the maltose. The protein concentration
